SUCCESS STORY Bürkert < > Novo Nordisk A new formulation line for insulin vialsThe Danish Pharmaceutical Group Novo Nordisk has chosen Bürkert, the fluid control specialists, to equip its latest production line for the formulation of insulin vials at its site in Chartres (Eure-et-Loir), France. A technical solution supported by Bürkert allows the pharmaceutical leader to simplify their processes and increase productivity. This plant is dedicated to the production and packaging of insulin products with nearly 20 million Euros invested to increase their capacity and build the latest in vial production facilities. “Our Chartres site is divided into three activities – NNP1 unit assigned to the production of 3 mL cartridges, NNP3 unit reserved for packaging products and the new u

Join for free to read